BC-CfE Pharmacovigilance 2022 Annual Report
BC-CfE Pharmacovigilance 2022 Annual Report Read More »
Quality and Safety
Antiretroviral Adverse Drug Reaction Report form
To report a suspected adverse drug reaction (“side effect”) to an antiretroviral medication, download and complete the Antiretroviral Adverse Drug Reaction Report form and fax or mail it to the BC-CfE Pharmacovigilance Initiative (address shown on the top of the form). To learn more about HIV drug safety monitoring and adverse drug reaction reporting, click
Antiretroviral Adverse Drug Reaction Report form Read More »
BC-CfE Response to COVID-19
During these uncertain and unprecedented times, the senior leadership of the BC Centre for Excellence in HIV/AIDS (BC-CfE) presented a webinar to inform and reassure its clients, staff, and stakeholders, their critical work, with only a few minor modifications, will continue during the global COVID-19 pandemic. Presented on March 25th, the webinar titled, “COVID-19, the
BC-CfE Response to COVID-19 Read More »
A decade of effective drug safety monitoring led by the BC-CfE
Ten years ago, the BC-CfE officially launched the Pharmacovigilance Initiative to closely monitor the safety of HIV antiretroviral drug treatment.
A decade of effective drug safety monitoring led by the BC-CfE Read More »